GENETIC SCREENING AND DIAGNOSIS OF HUMAN DISEASES
Cambridge Symposia
symposia at xensei.com
Thu Dec 19 14:34:28 EST 1996
For registration and hotel information please contact:
Cambridge Healthtech Institute
1037 Chestnut Street
Newton Upper Falls, MA 02164
USA
Phone: 617-630-1300
Fax: 617-630-1325
E-mail: chi at healthtech.com
http://www.healthtech.com/conferences/
Third Annual GENETIC SCREENING AND DIAGNOSIS OF HUMAN DISEASES
February 27-28, 1997
Fairmont Hotel
San Francisco, California
Scientific Advisory Committee
Dr. Ian Day, University College London Medical School
Dr. Thomas J. Meade, California Institute of Technology
Dr. David Moskowitz, St. Louis VA Medical Center
Dr. M. Allen Northrup, Lawrence Livermore National Laboratory
Preventative Molecular Medicine The Future of Molecular Medicine
Dr. Arno Motulsky, University of Washington
Current Methods to Find Disease Genes
Dr. Richard King, University of Minnesota
Basic Statistical Issues in Linkage Analysis and Association
Dr. Robert C. Elston, Case Western Reserve University
Interim Report from Task Force of Genetic Testing
Dr. Neil A. Holtzman, Johns Hopkins University
Individual Life Insurance, Risk Classification, and Genetics
Dr. Robert Gleeson, Northwestern Mutual Life Insurance
Insurance Issues Inherent in Medical Genetics and Molecular Medicine
Dr. Mary Kay Pelias, Genetics Society Fellow
Advances in Technology
The Advanced Technology Program: Tools for DNA Diagnostics
Dr. Stanley Abramowitz, National Institute of Standards and Tech.
Electron Transfer Mechanisms Through the DNA Double Helix
Dr. Thomas J. Meade, California Institute of Technology
Miniaturized Diagnostic Instruments
Dr. M. Allen Northrup, Lawrence Livermore National Laboratory
Polygenic Disease Diagnosis Using an Active Electronic Multiplex
Hybridization Device
Dr. Michael J. Heller, Nanogen, Inc.
Gene-Callingä: A Comprehensive System for Expression Monitoring
Dr. Gregory Went, CuraGen Corporation
GeneSpectrometryä- Genotyping by MALDI Mass Spectrometry
Dr. Lawrence Haff, PerSeptive Biosystems, Inc.
Managing Multigene Stratification Data
Dr. Chris Fields, Molecular Informatics, Inc.
Molecular Diagnostics
Diagnostic Challenge of Multigene Diseases
Dr. Margaret Bywater, OncorMed, Inc.
Leveraging Genomic Databases for the Discovery of Diagnostic Markers
for Disease
Dr. John Burczak, SmithKline Beecham Pharmaceuticals
Diagnostic Applications of GeneChipä DNA Probe Arrays
Dr. Robert Lipshutz, Affymetrix, Inc.
High Throughput Generation and Analysis of Gene Expression Patterns
Dr. Richard Kouri, Gene Logic, Inc.
Use of Structure-Specific Cleavage Technology to Detect Mutations and
Quantitate Gene Expression in Clinically Significant Samples
Dr. Lance Fors, Third Wave Technologies
A Suite of Mutation Analysis Methodologies Founded on Microplate Array
Diagonal Gel Electrophoresis (MADGE)
Dr. Ian Day, University College London Medical School
Screening for Trinucleotide Repeat Expansions and the RED Method
Dr. Martin Schalling, Karolinska Hospital, Sweden
Screening for Disease Susceptibility Genes
Is ACE D/D a Master Disease Genotype?
Dr. David Moskowitz, St. Louis VA Medical Center
Molecular Haplotyping of Genome Diversity
Dr. Gualberto Ruano, BIOS Laboratories
Molecular Genetics as a Tool in Clinical Trial Design
Dr. Glenn A. Miller, Genzyme Genetics
Use of Molecular Genetics in Patient and Disease Studies
Dr. Wendy Fibison, National Center for Human Genome Research
Genetic Susceptibility Testing in Alzheimer's Disease: Methodological
and Ethical Issues
Dr. Peter J. Whitehouse, University Hospitals of Cleveland,
and Stephen Post, Case Western Reserve University
More information about the Methods
mailing list